Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Vouche

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|April 3, 2014
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomyMichael Vouche, Ali Habib, Thomas J Ward, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2013
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolizationRiad Salem, Margaret Gilbertsen, Zeeshan Butt, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2013
Cancer concepts and principles: primer for the interventional oncologist-part IRyan Hickey, Michael Vouche, Daniel Y Sze, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2013
Cancer concepts and principles: primer for the interventional oncologist-part IIRyan Hickey, Michael Vouche, Daniel Y Sze, et al.
Journal of Hepatology|July 2, 2013
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resectionMichael Vouche, Robert J Lewandowski, Rohi Atassi, et al.
European Journal of Radiology|July 3, 2017
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolizationAhmed Gabr, Nadine Abouchaleh, Rehan Ali, et al.
BMC Cancer|February 21, 2020
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapyLigia Craciun, Roland de Wind, Pieter Demetter, et al.
Transplantation|April 24, 2015
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein ThrombosisRiad Salem, Michael Vouche, Talia Baker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2014
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapyRobert J Lewandowski, Khairuddin Memon, Mary F Mulcahy, et al.
Hepatology (Baltimore, Md.)|December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experienceRiad Salem, Ahmed Gabr, Ahsun Riaz, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|April 3, 2014
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomyMichael Vouche, Ali Habib, Thomas J Ward, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2013
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolizationRiad Salem, Margaret Gilbertsen, Zeeshan Butt, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2013
Cancer concepts and principles: primer for the interventional oncologist-part IRyan Hickey, Michael Vouche, Daniel Y Sze, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 2, 2013
Cancer concepts and principles: primer for the interventional oncologist-part IIRyan Hickey, Michael Vouche, Daniel Y Sze, et al.
Journal of Hepatology|July 2, 2013
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resectionMichael Vouche, Robert J Lewandowski, Rohi Atassi, et al.
European Journal of Radiology|July 3, 2017
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolizationAhmed Gabr, Nadine Abouchaleh, Rehan Ali, et al.
BMC Cancer|February 21, 2020
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapyLigia Craciun, Roland de Wind, Pieter Demetter, et al.
Transplantation|April 24, 2015
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein ThrombosisRiad Salem, Michael Vouche, Talia Baker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2014
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapyRobert J Lewandowski, Khairuddin Memon, Mary F Mulcahy, et al.
Hepatology (Baltimore, Md.)|December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experienceRiad Salem, Ahmed Gabr, Ahsun Riaz, et al.
Pageof 5